Insightful diabetes leaders discuss high-potential areas ranging from SGLT-2s in type 1 diabetes, personalized treatment plans, and the do-it-yourself Loop app Continue Reading »
Exciting and important news in the diabetes sphere from the biggest diabetes conferences around the world.
Insightful diabetes leaders discuss high-potential areas ranging from SGLT-2s in type 1 diabetes, personalized treatment plans, and the do-it-yourself Loop app Continue Reading »
How we talk about diabetes matters; using empowering, non-stigmatizing words is important when speaking with and about people with diabetes Continue Reading »
The benefits of measuring time in range, plus new care guidelines for adults with type 2 diabetes Continue Reading »
CGM data in people without diabetes, time-in-range and A1C benefits in large hybrid closed loop study, plus trial results studying Jardiance in type 1 as well as Lilly’s new GLP/GIP agonist therapy Continue Reading »
SGLT-1/2 therapy for type 1 diabetes, hybrid closed loop systems in teens and children, and the importance of glucose control as an outcome in addition to A1C! Continue Reading »
The most promising therapies in the pipeline, accuracy data on the FreeStyle Libre 2, and more Continue Reading »
The diaTribe Foundation and TCOYD hosted a panel discussion at the ADA 78th Scientific Sessions in Orlando, Florida; read about insights on how to improve diabetes care Continue Reading »
Kelly Close and Adam Brown led two panels on next-generation diabetes at The diaTribe Foundation’s third annual gathering during ADA 2018; plus highlights from the “after hours” fireside chat on patient-centric innovation Continue Reading »